Abstract
Fournier’s gangrene is a potentially fatal emergency condition characterized by necrotizing fasciitis and supported by an infection of the external genital, perineal and perianal region, with a rapid and progressive spread from subcutaneous fat tissue to fascial planes.
In this case report, a 52-year-old man, with a history of hepatitis C-virus (HCV)-related chronic liver disease and cocaine use disorder for which he was receiving methadone maintenance therapy, was admitted to the Emergency Department with necrotic tissue involving the external genitalia.
Fournier’s gangrene is usually due to compromised host immunity, without a precise cause of bacterial infection; here it is linked to a loco-regional intravenous injection of cocaine. A multimodal approach, including a wide surgical debridement and a postponed skin graft, was needed. Here we report this case, with a narrative review of the literature.
Keywords: Fournier's gangrene, Necrotizing Fasciitis, Surgery, Infection
1. Introduction
Fournier’s gangrene was described for the first time in 1764 by Baurienne as an idiopathic, necrotizing lethal process in a man affected by gangrene of the genitalia. However, the origin of this clinical condition must be linked to Jean Alfred Fournier who described a series of fatal cases of idiopathic gangrene of the genitalia with a sudden onset in 5 young men in 1883 [1]. Fournier’s gangrene is a potentially fatal condition; it is characterized by necrotizing fasciitis and supported by an infection of the external genital, perineal and perianal region, with a rapid and progressive spread from subcutaneous fat tissue to fascial planes [2].
This emergency condition always requires a multimodal approach: antibiotic therapy, surgery followed by intensive care, and oxygen hyperbaric therapy [3].
Because of its rarity, most of the limited knowledge about Fournier’s gangrene derives from case reports and retrospective studies with small sample size [4].
Here, in order to improve the knowledge concerning Fournier’s gangrene, we describe an unusual case due to injection of cocaine into the superficial dorsal vein of the penis, followed by a comprehensive literature review.
2. Material and methods
We performed a narrative review of the literature by searching “Fournier’s gangrene”, “necrotizing fasciitis” on PubMed and Scopus (Table). Case reports, case series, and reviews were chosen and used to extract data regarding gender, age, comorbidity, pathogens, number of surgical debridements performed, peri-operative outcomes, intra-and post-operative complications, length of hospital stay, and number of hospitalizations in intensive care units. Two authors (AB, AP) independently performed online bibliographic searches to identify titles and abstracts of interest. Full texts of relevant articles were further assessed for inclusion in this study.
Table 1.
review of the Literature up-to-date to July 2019
| Reference | Year | Gender | N.of cases | Mean age | Surgical debridement | Days of hospital stay | Sepsi / ICU | Hyperbaric oxygen therapy | Pathogen | N.of deaths |
|---|---|---|---|---|---|---|---|---|---|---|
| Del Zingaro et al. [36] | 2019 | M | 1 | 76 | 1 | ND | 0 | 0 | Pseudomonas putida, Stenotrophomonas maltophilia, Staphylococcus haemolyticus and Staphylococcus Warneri | 0 |
| Arora et al. [37] | 2019 | 50M | 50 | 53 | 1 | 12.6 | ND | ND | Escherichia coli, Staphylococci, Pseudomonas, Bacteroides, Streptococci | 12 |
| Ali et al. [38] | 2019 | M | 1 | 45 | 1 | ND | 1 | 0 | ND | 0 |
| Mostaghim et al. [39] | 2019 | M | 1 | 38 | 1 | ND | 0 | 0 | Escherichia coli, Enterococcus faecalis, Bacteroides thetaiotaomicron, Streptococcus agalactiae, Clostridium clostridioforme | 0 |
| Zhou et al. [40] | 2019 | M | 1 | 58 | 1 | ND | 1 | 0 | ND | 0 |
| Asian et al. [41] | 2019 | M | 1 | 12 | 0 | 8h | 2 | 0 | Pseudomonas aeruginosa | 1 |
| Heijkoop et al. [42] | 2019 | ND | 14 | ND | 6 | 36 | 9 | 0 | ND | 1 |
| Paoneet al. [43] | 2019 | M | 1 | 72 | >1 | ND | 2 | 0 | ND | 0 |
| Lin et al. [44] | 2019 | 118M | 118 | 58 | 1 | ND | ND | ND | ND | 17 |
| Akella et al. [45] | 2019 | M | 1 | 37 | 1 | ND | ND | 0 | Staphylococcus aureus, Streptococcus, Anaerobic bacteroides | 0 |
| Klement et al. [46] | 2019 | M | 1 | 53 | 1 | ND | 1 | ND | ND | 1 |
| Onder et al. [47] | 2019 | M | 1 | 64 | 2 | ND | ND | ND | ND | 0 |
| Bersoff-Matcha et al. [48] | 2019 | 39M 16F | 55 | ND | 1 | ND | 9 | ND | ND | 3 |
| Louro et al. [49] | 2019 | 14M 1F | 15 | 66.9 | 3.3 | 46.8 | ND | ND | Escherichia coli, MRSA, Streptococcus pyogenes, Enterococcus faecium, Enterococcus cloacae, Klebsiella pneumoniae, Streptococcus epidermidis, Bacteroides fragilis, Corynebacterium, Candida albicans, Aspergillus fumigatus | 0 |
| Ünverdi et al. [50] | 2019 | 13M | 13 | 54.3 | 1 | 42 | ND | ND | Bacteroides Fragilis, Escherichia coli, Klebsiella spp, Pseudomo-nas aeruginosa | 0 |
| Hong-Cheng et al. [51] | 2019 | 56M 4F | 60 | 53 | 1.17 | ND | 1 | 0 | Escherichia coli, Enterococcus faecalis, Proteus mirabilis, Klebsiella pneumoniae, Peptostreptococcus, Pseudomonas aeruginosa | 1 |
| Rachana et al. [52] | 2019 | M | 1 | 50 | 1 | 18 | 0 | 0 | Fusobacterium varium, Escherichia coli, Bacteroides fragilis | 0 |
| Joury et al. [53] | 2019 | M | 1 | 51 | 1 | ND | ND | 0 | MRSA, Edwardsiella tarda, Klebsiella oxytoca, Prevotella | 0 |
| Selvi et al. [54] | 2019 | 30M | 30 | 62.9 | 6 | 20 | 9 | ND | ND | 3 |
| Majdoub et al. [55] | 2018 | F | 1 | 70 | - | - | - | - | Escherichia coli, Bacteroides | 1 |
| Hahn et al. [56] | 2018 | 33M 11F | 44 | 54.4 | 3.3 | 47 | 18 | ND | Polymicrobial flora (Escherichia coli, Entero- coccus, Staphylococcus, Klebsiella) (7), Monomicrobial flora (Staphylococcus, Escherichia coli, Klebsiella, Enterococcus, Candida (22) | 9 |
| Overholt et al. [57] | 2018 | M | 1 | 44 | 2 | 13 | 0 | 0 | Escherichia coli, Enterococcus avium, Gemella morbillorum | 0 |
| Pehlivanli et al. [58] | 2018 | 19M 4F | 23 | 65.9 | 6 | 18 | ND | ND | Escherichia coli, Klebsiella, Staphylococci, Enterobacter | 5 |
| Kranz et al. [4] | 2018 | 15 4M | 154 | 62.7 | 4.2 | 26.6 | 104 | 13 | Mixed flora (73), Streptococci (12), Staphylo- cocci (10), Enterococcus (10), Citrobacter (1), Pseudomonas (1), Candida (2) | 17 |
| Kobayashi et al. [59] | 2018 | M | 1 | 68 | 1 | 59 | 1 | 0 | Escherichia coli | 0 |
| Pandey et al. [60] | 2018 | M | 1 | 65 | 1 | ND | ND | ND | ND | ND |
| Matsuura et al. [61] | 2018 | M | 1 | 88 | ND | ND | ND | 0 | ND | 1 |
| Sen et al. [62] | 2018 | M | 1 | 47 | 1 | 18 | 0 | 0 | Rhizobium radiobacter | 0 |
| Elsaket et al. [63] | 2018 | 43M 1F | 44 | 51 | 1.33 | 26 | 6 | ND | Staphylococcus aureus, Acinetobacter, Strep- tococcus pyogenes, Proteus mirabilis, | 5 |
| Heijkoop et al. [64] | 2018 | ND | 14 | ND | 6 | 36 | 8 | 0 | ND | 1 |
| Takano et al. [65] | 2018 | F | 1 | 44 | 1 | ND | ND | 0 | Streptococcus constellatus, Clostridium ramosum | 1 |
| Semenič et al. [66] | 2018 | M | 1 | 30 | 2 | 16 | 1 | 0 | Escherichia coli, Bacteroides fragilis, Prevo- tella oralis, Streptococcus anginosus | 0 |
| Abbas-Shereef et al. [67] | 2018 | M | 1 | 71 | >1 | 30 | 1 | 0 | Pseudomonas aeruginosa, Klebsiella pneu- moniae, Candida albicans, Staphylococci, Group A Streptococcus | 0 |
| Wetterauer et al. [68] | 2018 | 20M | 20 | 66 | 4 | ND | 15 | 0 | Escherichia coli, Klebsiella, Pseudomonas aeruginosa | 3 |
| Demir et al. [69] | 2018 | 49M 25F | 74 | 57.6 | 1.87 | 23.18 | ND | ND | Escherichia coli, Staphylococcus aureus, Streptococci, Enterobacter, Pseudomonas aeruginosa, Bacteroides, Proteus, Clostrid-ium | 6 |
| Chen et al. [70] | 2018 | M | 1 | 29 | 2 | 11 | 1 | 0 | Streptococcus Agalactiae, Staphylococcus haemolyticus, Escherichia coli, peptostrepto-cocci, Prevotella corporis | 0 |
| Yuan et al. [71] | 2018 | M | 1 | 62 | 1 | ND | 1 | ND | Enterococcus avium, Escherichia coli | ND |
| Katsimantas et al. [72] | 2018 | M | 1 | 68 | 2 | 17 | 0 | 0 | Enterococcus faecalis, Streptococcus gordo- nii, Prevotella melaninogenica | 0 |
| Althunayyan et al. [73] | 2018 | F | 1 | 36 | 2 | 31 | 1 | 0 | Escherichia coli, Acinetobacter baumannii | 0 |
| Pittaka et al. [74] | 2018 | F | 1 | 24 | >1 | 14 | ND | ND | ND | 0 |
| Taylor et al. [75] | 2018 | F | 1 | 58 | 1 | ND | 1 | ND | Bacteroides fragilis, Clostridium ramosum, Gram positive cocci | 1 |
| Dos Santos et al. [76] | 2018 | 29M 11F | 40 | 51.7 | 1.8 | 19.6 | 9 | ND | ND | 9 |
| Fukui et al. [77] | 2018 | M | 1 | 85 | 1 | 104 | 1 | 0 | Streptococcus dysgalactiae, Escherichia coli, Staphylococci | 0 |
| Kuzaka et al. [78] | 2018 | 13M | 13 | 59.6 | >1 | 31.9 | 0 | ND | Enterobacteriaceae, Bacteroides, Parabacte- roides, Klebsiella, Staphylococcus, Lactoba-cillus acidophilus, Escherichia coli | 0 |
| Goel et al. [79] | 2018 | M | 1 | 60 | 1 | 14 | 0 | 0 | ND | 0 |
| Ghodoussipour et al. [80] | 2018 | 54M | 54 | 49.3 | 3.9 | 37.5 | 53 | ND | ND | 3 |
| Tenόrio et al. [81] | 2018 | 99 M, 25F | 124 | 50.8 | ND | 21.7 | ND | 1 | Escherichia coli, Proteus, Klebsiella, Pseu- domonas, Staphylococci, Enterococcus, Clostridium | 32 |
| Weimer et al. [82] | 2017 | M | 1 | 55 | >1 | 90 | 1 | 0 | Parabacteroides distasonis, Prevotella melaninogenica, Fusobacterium nucleatum, Bacteroides | 0 |
| Wähmann et al. [83] | 2017 | F | 1 | 46 | 3 | ND | 1 | ND | Streptococci, Enterobacteria, gram+ | 0 |
| Wangetal. [84] | 2017 | M | 1 | 61 | 1 | ND | ND | ND | Klebsiella pneumoniae | 0 |
| Yücel et al. [85] | 2017 | UM, 14F | 25 | 54.3 | 2.4 | 21.4 | ND | 0 | ND | 1 |
| ϋreyen et al. [86] | 2017 | 18M, 11F | 29 | 51.5 | 1.8 | 11.5 | 17 | ND | Escherichia coli, Acinetobacter, Streptococci, Staphylococcus aureus, Pseudomonas, Klebsiella, | 6 |
| Dell'Atti et al. [87] | 2017 | M | 1 | 75 | 1 | 28 | 1 | 0 | ND | 0 |
| Yanaral et al. [88] | 2017 | 54M | 54 | 58.3 | 1.4 | 15.3 | ND | 0 | ND | 4 |
| Chia et al. [89] | 2017 | 42M, 17F | 59 | 56 | >1 | 19 | 11 | ND | Streptococci, Escherichia coli, Prevotella | 9 |
| Kordahi et al. [90] | 2017 | M | 1 | 57 | >1 | ND | ND | ND | ND | ND |
| Hong et al. [91] | 2017 | 18M, 2F | 20 | 61.8 | 1.55 | 36.9 | 15 | 0 | Escherichia coli, Streptococci, Proteus, Kleb- siella pneumoniae, Enterococcus faecium, Pseudomonas aeruginosa, Staphylococcus aureus | 5 |
| Sanders et al. [92] | 2017 | M | 1 | 70 | 2 | ND | 1 | 0 | Escherichia coli, P. mirabilis | 0 |
| Ferretti et al. [93] | 2017 | 19M, 1F | 20 | 56 | 4 | 31.7 | 17 | 4 | ND | 3 |
| Kumar et al. [94] | 2017 | M | 1 | 41 | 2 | 15 | 1 | 0 | Streptococcus anginosus, anaerobes, Gram - | 0 |
| loannidis et al. [95] | 2017 | 20M, 4F | 24 | 58.9 | 1 | 16 | 18 | 3 | Escherichia coli (11), Klebsiella pneumoniae (3), Pseudomonas aeruginosa (3), Acineto-bacter baumannii (2), Proteus mirabilis (2), Providencia stuartii (1) | 5 |
| Bocchiotti et al. [96] | 2017 | M | 1 | 40 | 3 | ND | 0 | 0 | Escherichia coli, Streptococcus pyogenes, Prevotella loescheii | 0 |
| Choi et al. [97] | 2017 | F | 1 | 31 | 1 | 17 | 0 | 0 | Streptococcus anginosus, Pseudomonas, Clostridium | 0 |
| Sawayama et al. [98] | 2017 | M | 1 | 66 | 1 | ND | 0 | 0 | ND | 0 |
| Laureman et al. [99] | 2017 | 125M, 43F | 168 | ND | >1 | ND | 92 | 0 | Enterococcus faecalis, Klebsiella pneumo- niae, Escherichia coli, Clostridium difficile | 6 |
| Smith et al. [100] | 2017 | M | 1 | 50 | >1 | ND | 1 | 0 | ND | 0 |
| Baek et al. [101] | 2017 | F | 1 | 57 | 1 | ND | 1 | ND | ND | 0 |
| Huang [102] | 2017 | M | 1 | 46 | 1 | ND | 1 | 0 | ND | 0 |
| Morais et al. [103] | 2017 | 12M, 3F | 15 | 70 | ND | 32 | ND | 0 | Escherichia coli, Proteus, Staphylococcus aureus, Enterococcus faecalis | 4 |
| Okumura et al. [104] | 2017 | M | 1 | 70 | 1 | 39 | 1 | 0 | Klebsiella pneumoniae, Group G Streptococ- cus | 0 |
| Osbun et al. [105] | 2017 | ND | 165 | 53.4 | 1.97 | 16.6 | 43 | ND | ND | 11 |
| Kahn et al. [106] | 2017 | M | 147 | 52 | 2.5 | 19 | 112 | ND | ND | 11 |
| Misiakos et al. [107] | 2017 | 47M, 15F | 62 | 63.7 | 4.8 | 19.7 | 32 | 0 | ND | 11 |
| Obi [108] | 2017 | 4M | 34.3 | 1 | 17.3 | 0 | 0 | Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis | 0 | |
| Pernetti et al. [109] | 2016 | M | 1 | 70 | 1 | 21 | 1 | ND | ND | 0 |
| Faria et al. [110] | 2016 | M | 1 | 46 | 1 | 4 | 1 | 0 | ND | 0 |
| Ozkan et al. [111] | 2016 | 7M, 5F | 12 | 62.4 | 5.7 | 19.6 | ND | 0 | Polymicrobial flora (6), monomicrobica (6) | 0 |
| Yoshino et al. [112] | 2016 | M | 1 | 64 | 1 | 33 | 1 | 0 | Streptococcus. alpha-emolitico | 0 |
| Crowell et al. [113] | 2016 | M | 1 | 54 | 3 | 18 | 1 | 0 | Rhizopus (zygomycosis) | 1 |
| Taken et al. [114] | 2016 | 57M, 8F | 65 | 52.5 | 2.5 | 9.2 | 13 | 0 | Escherichia coli, Streptococcus, Staphylococ- cus aureus, Enterobacter, Bacteroides, Pseu-domonas aeruginosa, Proteus, Clostridium | 6 |
| Wanis et al. [115] | 2016 | M | 1 | 28 | 1 | 14 | 1 | 0 | ND | 0 |
| Sheeny et al. [116] | 2016 | M | 1 | 48 | 2 | ND | 1 | 0 | Polymicrobial flora | 0 |
| Sarkut et al. [117] | 2016 | 32M, 32F | 64 | 57 | 3 | 16.6 | ND | ND | ND | 18 |
| Sinha et al. [118] | 2015 | F | 1 | 30 | 1 | ND | 1 | 0 | ||
| Marín etal. [119] | 2015 | 53M, 6F | 59 | 68 | ND | 24.4 | 50 | ND | ND | 15 |
| Chalya et al. [120] | 2015 | 82M, 2F | 84 | 34 | ND | 28 | ND | ND | 24 | |
| Namkoong et al. [121] | 2015 | M | 1 | 61 | 1 | ND | 1 | 0 | ND | 0 |
| Schulz et al. [122] | 2015 | M | 1 | 59 | >1 | ND | 1 | 0 | ND | 0 |
| McCormack et al. [123] | 2015 | 25M | 25 | 56.6 | 1.4 | ND | 3 | ND | Polymicrobial flora | 5 |
| Tarchouli et al. [124] | 2015 | 64M, 8F | 72 | 51 | 3.2 | 28.7 | 17 | 56 | Polymicrobial flora (37), Monomicrobial flora (1) | 12 |
| Paonam et al. [125] | 2015 | M | 1 | 65 | 1 | ND | 1 | 0 | Escherichia coli, Enterococcus | 0 |
| Oguz et al. [126] | 2015 | 34M, 9F | 43 | 52 | >1 | ND | 43 | 0 | Polymicrobial flora (Escherichia coli 48%) | 6 |
| Asahata et al. [127] | 2015 | M | 1 | 70 | 1 | ND | 0 | 0 | Listeria monocytogenes, Escherichia coli | 0 |
| Ye et al. [128] | 2015 | M | 1 | 47 | 1 | 21 | 0 | 0 | Pseudomonas aeruginosa | 0 |
| Danesh et al. [129] | 2015 | 8M | 8 | 44 | >1 | ND | ND | 0 | Enterococcus, Pseudomonas, Staphylococcus haemolyticus, Proteus, Clostridium | 3 |
| Ossibi et al. [130] | 2015 | M | 1 | 60 | 1 | ND | 0 | 0 | ND | 0 |
| Mahmoudi et al. [131] | 2015 | M | 1 | 44 | 1 | ND | 1 | 0 | ND | 0 |
| Cochetti et al. [22] | 2015 | 2M | 2 | 42.5 | 0.5 | ND | 2 | 1 | Staphylococcus warneri | 1 |
| Sarmah et al. [132] | 2015 | M | 1 | 68 | 1 | 1 | 1 | 0 | Bacteroides fragilis | 1 |
| Papadimitriou et al. [133] | 2015 | M | 1 | 56 | 1 | 90 | 1 | 0 | Polymicrobial flora | 0 |
| Ozsaker et al. [134] | 2015 | M | 1 | 69 | 1 | ND | 0 | 0 | ND | 0 |
| Garcia Marin et al. [135] | 2015 | 53M, 6F | 59 | 68 | ND | ND | 18 | 0 | ND | 15 |
| Toh et al. [136] | 2014 | M | 1 | 61 | 6 | ND | 1 | 0 | Polymicrobial flora | 0 |
| Parry et al. [137] | 2014 | M | 1 | 48 | 1 | ND | 0 | 0 | ND | 0 |
| Tena et al. [138] | 2014 | M | 1 | 73 | 1 | 55 | 1 | 0 | Actinomyces funkei, Clostridium hathewayi, Fusobacterium necrophorum | 0 |
| Matilsky et al. [139] | 2014 | M | 1 | 51 | 4 | 30 | 1 | 0 | Polymicrobial flora | 0 |
| Lee et al. [29] | 2014 | 3M | 3 | 50.7 | ND | ND | ND | ND | ND | ND |
| Di Serafino et al. [140] | 2014 | M | 1 | 63 | 1 | ND | ND | ND | ND | 0 |
| Galukande et al. [141] | 2014 | 2M | 2 | 35.5 | 2.5 | ND | 0 | 0 | ND | 0 |
| Tattersall et al. [142] | 2014 | M | 1 | 61 | 2 | 47 | 1 | ND | Escherichia coli | 0 |
| Omisanjo et al. [143] | 2014 | 11M | 11 | 51.9 | >1 | 22.7 | 7 | 0 | Klebsiella (10), Escherichia coli, Pseudomo- nas aeruginosa, no microbes (1) | 0 |
| Rubegni et al. [144] | 2014 | 2M | 2 | 58.5 | 1 | ND | 0.5 | 0 | ND | 1 |
| Dinc et al. [145] | 2014 | M | 1 | 51 | >1 | 16 | 0 | 0 | ND | 0 |
| Dayan et al. [146] | 2014 | M | 1 | 27 | >1 | ND | 0 | 0 | ND | 0 |
| Ludolph et al. [147] | 2014 | 3M | 3 | 48.7 | >1 | ND | 0 | 0 | ND | 0 |
| Ozkan et al. [148] | 2014 | 7M, 5 F | 12 | 62.4 | 5.7 | 19.6 | ND | 0 | Pseudomonas, Acinetobacter, Escherichia coli, Enterococcus, Stafilococcus aureus, Proteus, Corynebacterium, Polymicrobial flora (6) | ND |
| Shimizu et al. [149] | 2014 | M | 1 | 74 | 2 | ND | 0 | 0 | Proteus vulgaris, Prevotella denticola, Pepto- streptococcus species | ND |
| Ho et al. [150] | 2014 | F | 1 | 78 | 1 | 14 | 0 | 0 | ND | 1 |
| Aslanidis et al. [151] | 2014 | F | 1 | 23 | >1 | ND | 1 | 0 | Candida albicans, Staphylococcus epider- midis, Klebsiella pneumoniae | 0 |
| D'Arena et al. [152] | 2014 | M | 1 | 66 | 1 | ND | 0 | 0 | ND | 0 |
| Perkins et al. [153] | 2014 | M | 1 | 73 | 1 | ND | 0 | 0 | Candida albicans | 0 |
| Sliwinski et al. [154] | 2014 | M | 1 | 24 | >1 | ND | 1 | 0 | ND | 0 |
| Agostini et al. [155] | 2014 | M | 1 | 64 | 2 | 58 | 1 | 1 | Staphylococcus epidermidis, Proteus mirabi- lis, Enterococcus faecalis | 0 |
| Oymaci et al. [156] | 2014 | 10M, 6F | 16 | 61.2 | 4.44 | 25.5 | ND | 0 | Escherichia coli, Acinetobacter baumannii, Proteus mirabilis, Staphylococcus aureus, Enterococcus | 3 |
| Eskitascioglu et al. [157] | 2014 | 76M, 4F | 80 | 53.5 | 1.55 | 34.78 | ND | 0 | Polymicrobial flora (14), Escherichia coli, Staphylococcus aureus, Enterococcus, Acine-tobacter baumanii, Staphylococcus epider-midis, Proteus, etc. | 3 |
| Yilmazlar et al. [158] | 2014 | 81M, 39F | 120 | 58 | 3 | 14.5 | 48 | 0 | Escherichia coli, Streptococci, Enterococci, Staphylococci, Klebsiella, Pseudomonas, Proteus, fungi | 25 |
| Akbulut et al. [159] | 2014 | M | 1 | 77 | 1 | 20 | 0 | 0 | Escherichia coli | 0 |
| Coyne et al. [160] | 2014 | M | 1 | 48 | 1 | ND | 0 | 0 | ND | 0 |
| Li et al. [161] | 2014 | 48M, 3 F | 51 | 49.7 | >1 | 17 | ND | 0 | Escherichia coli, Streptococcus, Staphylococcus aureus, Pseudomonas, Proteus, Clostrid-ium, Bacteroides | |
| Oyaert et al. [162] | 2014 | M | 1 | 43 | 1 | 63 | 1 | 0 | Atopobium | 0 |
| Lee et al. [163] | 2013 | M | 1 | 47 | >1 | ND | 0 | 0 | Enterococcus, Enterobacter | 0 |
| Abate et al. [164] | 2013 | M | 1 | 63 | 1 | 21 | 0 | 0 | Enterococcus faecalis, Citrobacter freundii, Pseudomonas aeruginosa, Escherichia coli, Bacteroides fragilis, Bacteroides ovatus | 0 |
| Anantha et al. [165] | 2013 | M | 1 | 59 | 1 | 16 | 1 | 0 | Streptococcus anginosus | 0 |
| Benjelloun et al. [166] | 2013 | 44M, 6F | 50 | 48 | 2.5 | 21 | 11 | 0 | Escherichia coli, Klebsiella | 12 |
| Pastore et al. [167] | 2013 | M | 1 | 60 | >1 | 34 | 0 | 1 | Streptococcus A | 0 |
| Eray et al. [168] | 2013 | 34M, 14F | 48 | 53.7 | ND | 25.3 | ND | 0 | ND | 9 |
| Bjurlin et al. [169] | 2013 | 40M, 1F | 41 | 49 | ND | ND | ND | ND | Polymicrobial flora (34), Bacteroides (43.9%), Escherichia coli (36.6%), Prevotella, Streptococci, Staphylococcus aureus | 2 |
| Park et al. [170] | 2013 | M | 1 | 59 | >1 | ND | 0 | 0 | ND | 0 |
| Subramaniam et al. [171] | 2013 | M | 1 | 80 | 3 | ND | 1 | 0 | Escherichia coli, Anaerobes | 0 |
| Sabzi Sarvestani et al. [172] | 2013 | 28M | 28 | 44.6 | 2.2 | 17.22 | ND | 0 | Escherichia coli, Bacteroides, Streptococci, Enterococci, Staphylococci, Pseudomonas, Klebsiella, Proteus | 10 |
| Katib et al. [173] | 2013 | 20M | 20 | 55.95 | 1.7 | 22.3 | 1 | 0 | Acinetobacter spp. (most common) | 0 |
| Czymek et al. [174] | 2013 | 72M, 14F | 86 | 57.9 | 4 | 52 | 52 | ND | Polymicrobial flora (71), Escherichia coli, Enterococci, Streptococci, Pseudomonas, Staphylococci, etc. | 14 |
| Akilov et al. [175] | 2013 | 28M | 28 | 47.1 | 3.5 | 24.4 | 8 | 0 | Monomicrobial flora (18), Staphylococci, Streptococci, Enterobacter, Pseudomonas | 0 |
| Bakari et al. [176] | 2013 | 10M | 10 | 50.5 | ND | ND | ND | 0 | ND | ND |
| Avakoudjo et al. [177] | 2013 | ND | 72 | ND | ND | 72 | ND | ND | Escherichia coli, Staphylococci, Pseu- domonas aeruginosa, Klebsiella | 7 |
| Chan et al. [178] | 2013 | M | 1 | 78 | 1 | ND | 1 | 0 | Escherichia coli | 0 |
| Chan et al. [179] | 2013 | M | 1 | 49 | 15 | ND | 0 | 0 | Escherichia coli, Streptococci, Arcanobacte- rium | 0 |
| Aliyu et al. [180] | 2013 | 43M | 43 | 37.82 | >1 | 28 | ND | 0 | Polymicrobial flora (27) | 6 |
| Ozkan et al. [181] | 2013 | F | 1 | 43 | 4 | ND | 1 | 0 | ND | 0 |
| Khan et al. [33] | 2013 | M | 1 | 47 | 3 | ND | 1 | 0 | ND | 0 |
| Vyas et al. [182] | 2013 | 30M | 30 | 39.6 | 2.2 | 9.7 | ND | 0 | Escherichia coli, anaerobes, Streptococci, Pseudomonas, Staphylococci | 6 |
ICU=intensive care unit
ND=not defined
3. Case report
A 52-year-old man with a history of a cocaine use disorder, who was in methadone maintenance therapy and affected by HCV-related chronic liver disease, was admitted to the Emergency Department of a high-volume hospital. At admission to our institution, he presented with fever, acute renal impairment, anuria, poor hygienic conditions, and necrotic tissue involving the external genitalia (Figure 1). The laboratory tests showed 29 x 109/L white blood cells with 95% neutrophils, haemoglobin 15.6 g/dl, glucose 103 mg/dl, aspartate transaminase 79 UI/L, alanine transaminase 68 UI/L, creatinine 2.58 mg/dl, C-reactive protein 56.2 mg/dl, procalcitonin >100 ng/ml. HIV testing was negative. The patient reported no other urological symptoms at hospital afdmission. He had a Charlson Comorbidity Index score of 2 and an Eastern Cooperative Oncology Group (ECOG) of 1, with no referring major comorbidities.
Figure 1.

The physical examination was notable for necrotic-appearing tissue in the entire penis and scrotum, with areas of induration and crepitus
A scrotal ultrasound examination was performed. It showed the right testis augmented in volume with completely altered echogenicity, augmented vascular sign and hypoechoic areas. The left epididymis and involucres had irregular echogenicity. The left testis appeared to have irregular echogenicity and was hypervascularized with hypoechoic areas. A left hydrocele was present. Computed tomography (CT) was performed. It confirmed phlogosis and edema of the scrotum, with the right testis unrecognizable. Skin, subcutaneous planes, spermatic cord were thickened. Inguinal bilateral and right external iliac lymphadenopathy was described on CT.
The patient underwent resuscitation intravenous fluid support; antibiotic therapy was administered with tigecycline and meropenem. A single, prompt, extended surgical debridement of external genital, perineal, perianal and infrapubic regions to healthy tissue was performed. The patient also underwent at the same time right orchiectomy.
The microbiologic culture of the wound specimen revealed Staphylococcus lugdunensis with tigecycline susceptibility. Urine and blood samples cultures were negative. Tigecycline and meropenem were administered until discharge.
The anuric condition persisted for 24 hours; then polyuria developed, but with a renal impairment that required treatment with dialysis.
Five days after the surgical debridement the patient reported the injection of cocaine into the superficial dorsal vein of the penis.
The histologic report confirmed an inflammatory necrotizing process of subcutaneous tissue that expanded to skin, testicular and epididymis parenchyma, rete testis and peritesticular tissue.
No other wound treatments were performed for the wide extension of involved cutaneous area and the correct development of granulation tissue.
The patient was discharged 17 days after the surgical debridement and was admitted to the waiting list for a skin graft, which was successfully performed 1 month later.
Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board of Perugia University.
Written informed consent was obtained from the patient.
4. Discussion
Fournier’s gangrene is a surgical emergency characterized by necrotizing fasciitis of the genital, perineal and perianal soft tissue. It is a rare condition, representing 0.02% of hospitalizations, with an estimated incidence of 1.6 for 100.000 males/year [5]. This condition affects both males and females. Males are more affected than females with a ratio 10:1, and age of onset is becoming older (between 60s and 70s) [6].
The patient in our case of necrotizing fasciitis was 52 years old. Fournier’s gangrene was initially described as an idiopathic process, which has been found to be true in only a few cases. Often the initial cause is an infection involving the ano-rectum (30-50%), uro-genitalia (20-40%) and genital skin (20%). [7, 8, 9]. Infection results in inflammation and edema, which leads to obliterating endarteritis of the subcutaneous vessels [10]. The resulting lower blood support leads to peripheral dissection, with consequent spread of infection between the subcutaneous tissue and the skin. The reduction of the blood supply therefore generates gancrena [11].
This necrotizing fasciitis may be due to a condition of compromised host immunity, like diabetes, alcoholism, human immunodeficiency syndrome (HIV), lymphoproliferative diseases, arterial hypertension, renal and hepatic insufficiency, obesity, dementia, tobacco consumption, chronic steroid abuse, chemo- and radiotherapy, or cancer and surgical treatment [12, 13, 14, 15, 16, 17, 18, 19, 20]. In our case, a correlation between gangrene and a patient with a history of cocaine abuse undergoing methadone substitution treatment has been highlighted. The patient was also affected by HCV-related chronic liver disease.
The pathogen involved is both aerobic and anaerobic, gram-negative and gram-positive. Some authors suggest the use of three different antibiotic classes to start an empiric treatment to cover all types of pathogen. In most of the cases, a polymicrobial infection (54%) is demonstrated, and Escherichia coli is the most frequently isolated pathogen (46.6%). The pathogens with a lower incidence are the streptococcus, bacteroides, enterobacter, staphylococcus, enterococcus, pseudomonas, corynebacterium, and Klebsiella pneumoniae [21]. Our review confirms that E. coli is the most involved pathogen (53,1%) and a polymicrobial infection the most common cause (68%) of Fournier’s gangrene. However, many authors suggest the use of broad-spectrum penicillin or third-generation cephalosporins, an aminoglycoside (e.g. gentamicin) and metronidazole or clindamycin [11]. In our case tigecycline and meropenem were administered to cover aerobic gram-positive and gram-negative pathogens, as well as anaerobic gram-positive and gram-negative pathogens. The administration was related to renal-function impairment.
The risk of a fatal event makes this necrotizing fasciitis an emergency clinical condition. Prompt management is mandatory; hemodynamic support with resuscitation with fluids, board-spectrum parental antibiotics and surgical debridement of the involved region are the main procedures [22, 23]. Thanks to these approaches, the mortality linked to Fournier’s gangrene has dropped from between 20% and 88% to lower than 10% [24, 25]. On the basis of the data we collected, the reported mortality was 14,1 %. In our case, the patient survived the acute condition, and he is still alive.
The surgical debridement must be performed within a few hours of hospitalization, and the removal of necrotic tissue helps in stopping progression of necrotizing fasciitis and in reducing the risk of death [26]. Nevertheless, Proud et al, in a retrospective study of 219 patients found no differences in mortality in patients treated within 24 hours and those not treated. The authors linked this result to the severity of the infection [27]. For some authors (Chowla et al), more than one surgical debridement is necessary to obtain adequate infection control [28]. From our review of literature, more than one surgical debridement was performed in more than 60% of cases. In our case, we performed one surgical debridement, with the goal of obtaining a partial resection of viable tissue adjacent to the necrotic one.
Negative pressure wound therapy (NPWT) may represent a solution to the risk of infection of the large open wound that usually remains after a surgical debridement, since the patient’s poor condition it may be difficult to create a skin flap with which to cover the wound [29]. In NPWT the wound is exposed to a sub-atmospheric pressure between 50 and 125 mm Hg in order to increase blood supply, migration of inflammatory cells, and removal of exudates [11]. According to Chang et al, NPWT allows less frequent wound medication and reduction of pain and length of hospital stay [30].
The use of hyperbaric oxygen therapy (HBOT) is increasing in the management of Fournier’s gangrene, but evidence of efficacy is lacking [31]. In the HBOT treatment, the patient inhales 100% O2 in increased ambient pressure (2 – 3 atmospheres). HBOT has bactericide and bacteriostatic effects on anaerobic pathogens, in particular. It also improves bacterial lysis by leukocytes and stimulates collagen formation and superoxide dismutase with tissue survival [11,13]. Some authors have reported the range of mortality to be between 16% and 30%, whereas for the patients who undergo HBOT, the mortality is found to be approximately 17.6%.
In our case, our patient obtained a complete resolution of the necrotizing process without NPWT or HBOT, and a skin graft was then performed.
Cocaine, as described by Burnett [32], could be associated with priapism, and when administered into the corpora cavernosa, it could produce a prolonged erection [33]. In our knowledge, only two other cases of Fournier’s gangrene associated with penile injection of cocaine [33, 34] and three cases of penile necrosis [35] have been described. In both cases of Fournier’s gangrene, the necrosis was limited to the penis. The mechanism behind the necrotizing fasciitis after intra-corpora cavernosa injection of cocaine could be dual: cocaine has an intensive vasoconstrictive action that could lead to dermal necrosis that could be complicated by superinfection [33] or by inoculation of infective agents [34]. In our case, we believe that the inoculation of infective agents was the most plausible mechanism, since a skin commensal bacterium was involved.
5. Conclusion
Fournier’s gangrene is a potentially fatal condition that must be treated in a multimodal setting.
Here we report a rare case of genital and perineal necrotizing fasciitis after a loco-regional intravenous injection of cocaine.
To offer the patient the possibility of survival, a prompt application of a multimodal approach with intravenous fluid support, antibiotic therapy and aggressive surgical debridement is mandatory.
Footnotes
Conflict of interest
Conflict of interest statement: Authors state no conflict of interest.
References
- [1].Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P.. Fournier’s gangrene. A clinical review. Arch Ital UrolAndrol. 2016;88(3) doi: 10.4081/aiua.2016.3.157. [DOI] [PubMed] [Google Scholar]
- [2].Marchesi A, Marcelli S, Parodi PC, Perrotta RE, Riccio M, Luca Vaienti L. Necrotizing fasciitis in aesthetic surgery: a review of the literature. AesthPlastSurg. 2017;41:352–358. doi: 10.1007/s00266-016-0754-2. [DOI] [PubMed] [Google Scholar]
- [3].Ueshima J, Maeda K, Wakabayashi H, Nishioka S, Nara S, Nakatani H. Availability of early, intensive, and continuous nutrition management for Fournier’s gangrene with rectal cancer: a case report. J AcadNutr Diet. 2016;Vol. 116(6):909–916. doi: 10.1016/j.jand.2015.09.021. No. [DOI] [PubMed] [Google Scholar]
- [4].Kranz J, Schlager D, Anheuser P, Mühlstädt S. Desperate need for better management of Fournier’s gangrene. Cent European J Urol. 2018;71:360–365. doi: 10.5173/ceju.2018.1740. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD. Fournier’s gangrene: Population based epidemiology and outcomes. J Urol. 2009;181:2120–2126. doi: 10.1016/j.juro.2009.01.034. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Rodríguez Alonso A, Pérez García MD, Núñez López A, Ojea Calvo A, Alonso Rodrigo A, Rodríguez Iglesias B, Barros Rodríguez JM, Benavente Delgado J, Nogueira March JL. Fournier’s gangrene: anatomo-clinical features in adults and children. Therapy update. ActasUrolEsp. 2000;24(4):294–306. doi: 10.1016/s0210-4806(00)72452-1. [DOI] [PubMed] [Google Scholar]
- [7].Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000;87:718–728. doi: 10.1046/j.1365-2168.2000.01497.x. [DOI] [PubMed] [Google Scholar]
- [8].Cirocchi R, Randolph JJ, Montedori A, Cochetti G, Arezzo A, Mearini E, Abraha I, Trastulli S. Staples versus sutures for surgical wound closure in adults. Cochrane Database of Systematic Reviews. 2014. Issue 8. Art. No.: CD011250.
- [9].Desiderio J, Trastulli S, Listorti C, Milani D, Cerroni M, Cochetti G, Cirocchi R, Boselli C, Parisi A, Mearini E, Noya G. Surgical approach of complicated diverticulitis with colovesical fistula: technical note in a particular condition. Cent Eur J Med. 2012;7:5:578–583. [Google Scholar]
- [10].Korkut M, Icoz G, Dayangac M, Akgun E, Yeniay L, Erdogan O. Outcome analysis in patients with Fournier’s gangrene. Report of 45 cases. Dis Colon Rectum. 2003;46:649–652. doi: 10.1007/s10350-004-6626-x. et al. [DOI] [PubMed] [Google Scholar]
- [11].Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contemporary diagnosis and management of Fournier’s gangrene. TherAdvUrol. 2015;7(4):203–215. doi: 10.1177/1756287215584740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Pastore AL, Palleschi G, Ripoli A. A multistep approach to manage Fournier’s gangrene in a patient with unknown type II diabetes: surgery, hyperbaric oxygen, and vacuum-assisted closure therapy: a case report. J Med Case Rep. 2013;7:1. doi: 10.1186/1752-1947-7-1. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Rosa I, Guerreiro F. Hyperbaric oxygen therapy for the treatment of Fournier’s gangrene: a review of 34 cases. Acta Med Port. 2015;28(5):619–623. doi: 10.20344/amp.6300. [DOI] [PubMed] [Google Scholar]
- [14].Trastulli S, Barillaro I, Desiderio J, DI Rocco G, Cochetti G, Mecarelli V, Cirocchi R, Santoro A, Boselli C, Redler A, Avenia N, Noya G. Colonic explosion during treatment of radiotherapy complications in prostatic cancer. Oncol Lett. 2012;4(5):915–918. doi: 10.3892/ol.2012.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Cochetti G, Del Zingaro M, Boni A, Cocca D, Panciarola M, Tiezzi A, Gaudio G, Balzarini F, Ursi P, Mearini E. Colovesical fistula: review on conservative management, surgical techniques and minimally invasive approaches. G Chir. 2018;39(4):195–207. [PubMed] [Google Scholar]
- [16].Cirocchi R, Arezzo A, Renzi C, Cochetti G, D’Andrea V, Fingerhut A, Mearini E, Binda GA. Is laparoscopic surgery the best treatment in fistulas complicating diverticular disease of the sigmoid colon? A systematic review. Int J Surg. 2015;24(Pt A):95–100. doi: 10.1016/j.ijsu.2015.11.007. [DOI] [PubMed] [Google Scholar]
- [17].Cirocchi R, Cochetti G, Randolph J, Listorti C, Castellani E, Renzi C, Mearini E, Fingerhut A. Laparoscopic treatment of colovesical fistulas due to complicated colonic diverticular disease: a systematic review. Tech Coloproctol. 2014;18(10):873–885. doi: 10.1007/s10151-014-1157-5. Oct; [DOI] [PubMed] [Google Scholar]
- [18].Giovanni C, Emanuele C, Francesco B, Emanuele L, Andrea B, Solajd P, Ettore M. Laparoscopic conservative treatment of colo-vesical fistula: a new surgical approach. IntBraz J Urol. 2013;39(5):752–753. doi: 10.1590/S1677-5538.IBJU.2013.05.19. [DOI] [PubMed] [Google Scholar]
- [19].Cochetti G, Cottini E, Cirocchi R, Pansadoro A, Lepri E, Corsi A, Barillaro F, Mearini E. Laparoscopic conservative surgery of colovesical fistula: is it the right way?WideochirInne Tech Maloinwazyjne. 2013;8(2):162–165. doi: 10.5114/wiitm.2011.32808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Cochetti G, Lepri E, Cottini E, Cirocchi R, Corsi A, Barillaro F, Boni A, Mancuso R, Solajd P, Mearini E. Laparoscopic conservative treatment of colo-vesical fistulas following trauma and diverticulitis: report of two different cases. Cent Eur J Med. 2013;8:790–794. [Google Scholar]
- [21].Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of Fournier’s gangrene in past five years. Springerplus. 2015;4:14. doi: 10.1186/s40064-014-0783-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Cochetti G, Barillaro F, Cottini E, D’Amico F, Pansadoro A, Pohja S, Boni A, Cirocchi R, Grassi V, Mancuso R, Silvi E, Ioannidou K, Egidi MG, Poli G, Mearini E. Pneumoscrotum: report of two different cases and review of the literature. TherClin Risk Manag. 2015;11:581–587. doi: 10.2147/TCRM.S77326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Stevens DL, Bisno AL, Chambers HF, Patchen Dellinger E, Goldstein EJC, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infection: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–e52. doi: 10.1093/cid/ciu444. [DOI] [PubMed] [Google Scholar]
- [24].Osbun N, Hampson LA, Holt SK, Gore JL, Wessells H, Voelzke bb. Low-volume vs high-volume centers and management of Fournier’s gangrene in washington state. J Am CollSurg. 2017;Vol. 2243:270–275. doi: 10.1016/j.jamcollsurg.2016.11.012. No. e1. [DOI] [PubMed] [Google Scholar]
- [25].Sorensen MD, Krieger JN, Rivara FP, Klein MB, Wessells H. Fournier’s gangrene: management and mortality predictors in a population based study. J Urol. 2009;182(6):2742–2747. doi: 10.1016/j.juro.2009.08.050. Dec; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].Thwaini A, Khan A, Malik A. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006;82:516–519. doi: 10.1136/pgmj.2005.042069. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Proud D, Raiola F, Holden D, Eldho P, Capstick R, Khoo A. Are we getting necrotizing soft tissue infections right? A 10-year review. ANZ J Surg. 2014;84:468–447. doi: 10.1111/ans.12412. [DOI] [PubMed] [Google Scholar]
- [28].Chowla SN, Gallop C, Mydio JH. Analysis of repeated surgical debridement. EurUrol. 2003;43:572–575. doi: 10.1016/s0302-2838(03)00102-7. [DOI] [PubMed] [Google Scholar]
- [29].Lee JY, Jung H, Kwon H, Jung SN. Extended negative pressure wound therapy-assisted dermatotraction for the closure of large open fasciotomy wounds in necrotizing fasciitis patients. Word J Emerg Surg. 2014;9:29. doi: 10.1186/1749-7922-9-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Chang FS, Chou C, Hu CY, Huang SH. Suture technique to prevent air leakage during negative-pressure wound therapy in Fourniere Gangrene. Plast Reconstr Surg Glob Open. 2018;6(1):e1650. doi: 10.1097/GOX.0000000000001650. Jan 25; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Thrane JF, Ovesen T. Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizinf soft tissue infection: a systematic review. Infect Dis (Lond) 2019;51(7):485–492. doi: 10.1080/23744235.2019.1597983. Jul. [DOI] [PubMed] [Google Scholar]
- [32].Burnett AL, Sharlip ID. Standard operating procedure for priapism. J Sex Med. 2013;10(1):180–194. doi: 10.1111/j.1743-6109.2012.02707.x. [DOI] [PubMed] [Google Scholar]
- [33].Khan F, Mukhtar S, Anjum F, Tripathi B, Sriprasad S, Dickinson IK, Madaan S. Fournier’s gangrene associated with intradermal injection of cocaine. J Sex Med. 2013;10:1184–1186. doi: 10.1111/jsm.12055. [DOI] [PubMed] [Google Scholar]
- [34].Mouraviev VB, Pautler SE, Hayman WP. Fournier’s gangrene following penile self-injection with cocaine. Scand J UrolNephrol. 2002;36:317–318. doi: 10.1080/003655902320248326. [DOI] [PubMed] [Google Scholar]
- [35].Carey F, Dinsmore WW. Cocaine-induced penile necrosis. Int J STD AIDS. 2004;15:424–425. doi: 10.1258/095646204774195317. [DOI] [PubMed] [Google Scholar]
- [36].Del Zingaro M, Boni A, Paladini A, Rossi de Vermandois JA, Ciarletti S, Felici G, Ursi P, Cirocchi R, Mearini E. Fournier’s gangrene secondary to locally advanced prostate cancer: case report and review of the Literature. G Chir. 2019 in press. [PubMed] [Google Scholar]
- [37].Arora A., Rege S., Surpam S., Gothwal K.. Narwade A.. Predicting Mortality in Fournier Gangrene and Validating the Fournier Gangrene Severity Index: Our Experience with 50 Patients in a Tertiary Care Center in India. Urologia Internationalis. 2019;102(3):311–318. doi: 10.1159/000495144. &. [DOI] [PubMed] [Google Scholar]
- [38].Ali T, Bowles M, Dastouri D, Allen N. Low thrombin tissue sealant ARTISS (Baxter), in complex primary closure after Fournier’s gangrene. Journal of Surgical Case Reports. 2019. Feb 25;2019(2) [DOI] [PMC free article] [PubMed]
- [39].Mostaghim A., Dhanani M. Ingalls R. R. Fournier’s gangrene as an initial manifestation of acute promyelocytic leukemia: A case report and review of the literature. SAGE Open Medical Case Reports. 2019. &. Mar 1;7. [DOI] [PMC free article] [PubMed]
- [40].Zhou Z., Guo F.. Huan J.. Fournier’s Gangrene With Septic Shock and Multiple Organ Dysfunction Syndrome. The International Journal of Lower Extremity Wounds. 2019;18(1):94–96. doi: 10.1177/1534734618818685. &. Mar. [DOI] [PubMed] [Google Scholar]
- [41].Aslan N., Yildizdas D., Horoz O. O.. Ozden O.. Fatal Agranulocytosis and Fournier’s Gangrene due to the Use of Metamizole. The Indian Journal of Pediatrics. 2019;86(3):310–311. doi: 10.1007/s12098-018-2799-5. &. Mar. [DOI] [PubMed] [Google Scholar]
- [42].Heijkoop B., Parker N.. Spernat D.. Fournier’s gangrene: not as lethal as previously thought? A case series. ANZ J Surg. 2019;89(4):350–352. doi: 10.1111/ans.14760. &. Apr. [DOI] [PubMed] [Google Scholar]
- [43].Paone R. Romsi P. A Case of Acute Aortoiliac Occlusive Disease Presenting as Cauda Equina Syndrome and Fournier´s Gangrene. Case Reports in Surgery. 2019. pp. 1–3. &. [DOI] [PMC free article] [PubMed]
- [44].Lin T., Cheng I., Ou C., Tsai Y., Tong Y., Cheng H. Cheng, Y. Incorporating Simplified Fournier’s Gangrene Severity Index with early surgical intervention can maximize survival in high‐risk Fournier’s gangrene patients. International Journal of Urology. 2019. …. Apr 18. [DOI] [PubMed]
- [45].Akella P, Mishra AK, Grewal H. Fournier’s gangrene following piquerism. Am J Med Sci. 2019. Apr26 [ahead of print] [DOI] [PubMed]
- [46].Klement RJ, Schäfer G,. Sweeney RA.. A fatal case of Fournier’s gangrene during neoadjuvant radiotherapy for rectal cancer. Strahlenther Onkol. 2019;195(5):441–446. doi: 10.1007/s00066-018-1401-4. &. May. [DOI] [PubMed] [Google Scholar]
- [47].Onder C. E., Gursoy K., Kuskonmaz S. M., Kocer U.. Culha C.. Fournier’s gangrene in a patient on dapagliflozin treatment for Type 2 Diabetes. J Diabetes. 2019;11(5):348–350. doi: 10.1111/1753-0407.12896. &. May. [DOI] [PubMed] [Google Scholar]
- [48].Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH. Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases. Ann Intern Med. 2019 doi: 10.7326/M19-0085. May 7. [DOI] [PubMed] [Google Scholar]
- [49].Louro JM, Albano M, Baltazar J, Vaz M, Diogo C, Ramos S, Cabral L. Fournier’s Gangrene: 10-Year Experience of a Plastic Surgery and Burns Department at a Tertiary Hospital. Acta Med Port. 2019;32(5):368–374. doi: 10.20344/amp.11003. May 31; [DOI] [PubMed] [Google Scholar]
- [50].Ünverdi ÖF, Kemaloğlu CA. A Reliable Technique in the Reconstruction of Large Penoscrotal Defect: Internal Pudendal Artery Perforator Flap. Urology. 2019;128:102–106. doi: 10.1016/j.urology.2019.02.028. Jun. [DOI] [PubMed] [Google Scholar]
- [51].Lin HC, Chen ZQ, Chen HX, He QL, Liu ZM, Zhou ZY, Shi R, Ren DL. Outcomes in patients with Fournier’s gangrene originating from the anorectal region with a particular focus on those without perineal involvement. Gastroenterol Rep (Oxf) 2019;7(3):212–217. doi: 10.1093/gastro/goy041. Jun. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [52].Rachana K, Biswas R, Bhat P, Sistla S, Kumari S, Kate V. Rare isolation of Fusobacterium varium from a case of Fournier’s gangrene. Anaerobe. 2019;57:82–85. doi: 10.1016/j.anaerobe.2019.03.020. Jun. [DOI] [PubMed] [Google Scholar]
- [53].Joury A, Mahendra A, Alshehri M, Downing A.. Extensive necrotizing fasciitis from Fournier’s gangrene. Urol Case Rep. 2019 doi: 10.1016/j.eucr.2019.100943. Jun 9;26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [54].Selvi I, Aykac A, Baran O, Burlukkara S, Ozok U, Sunay MM. A different perspective for morbidity related to Fournier’s gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier’s gangrene? [DOI] [PubMed]
- [55].Majdoub W, Mosbahi A, Bonbled F. Sudden unexpected death due to Fournier gangrene. Forensic Sci Med Pathol. 2019;15(1):155–158. doi: 10.1007/s12024-018-0030-7. Mar. [DOI] [PubMed] [Google Scholar]
- [56].Hahn HM, Jeong KS, Park DH, Park MC, Lee IJ. Analysis of prognostic factors affecting poor outcomes in 41 cases of Fournier gangrene. Ann Surg Treat Res. 2018;95(6):324–332. doi: 10.4174/astr.2018.95.6.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [57].Overholt T, Hajiran A, Ueno C, Zaslau S. Fournier’s Gangrene of the Penis following a Human Bite Wound. Case Reports in Urology. 2018;2018:9798607. doi: 10.1155/2018/9798607. Oct 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [58].Pehlivanlı F, Aydin O. Factors Affecting Mortality in Fournier Gangrene: A Single Center Experience. Surgical infection. 2018;Vol. 19(X) doi: 10.1089/sur.2018.208. No. [DOI] [PubMed] [Google Scholar]
- [59].Kobayashi D, Masubuchi M, Takase T, Ichikawa T, Deguchi T, Yaguchi T. Fournier’s gangrene caused by penetration of a rectal cancer followed by neoadjuvant chemotherapy. Surg Case Rep. 2018;4(1):123. doi: 10.1186/s40792-018-0526-0. Sep, 26; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [60].Pandey S, Sharma D, Aggarwal A, Sharma A. Isolated Fournier’s gangrene of the penis with penile autoamputation. BMJ Case Rep. 2018. Sep 19;2018. [DOI] [PMC free article] [PubMed]
- [61].Matsuura H, Iwasa K.. Fournier gangrene. Cleve Clin J Med. 2018;85(9):664–665. doi: 10.3949/ccjm.85a.18036. Sep. [DOI] [PubMed] [Google Scholar]
- [62].Sen V, Sen P, Sahin MO. Fournier gangrene due to Rhizobium Radiobacter. Pak J Med Sci. 2018;34(4):1027–1029. doi: 10.12669/pjms.344.14489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [63].Elsaket AE, Maharajh S, Urry RJ. The presentation, management and outcomes of Fournier’s gangrene at a tertiary urology referral centre in South Africa. S Afr Med J. 2018;108(8):671–676. doi: 10.7196/SAMJ.2018.v108i8.13100. Jul 25; [DOI] [PubMed] [Google Scholar]
- [64].Heijkoop B, Parker N, Spernat D. Fournier’s gangrene: not as lethal as previously thought? A case series. ANZ J Surg. 2018. Sep 2. [DOI] [PubMed]
- [65].Takano N, Yatabe MS, Yatabe J, Kato M, Sueoka D, Iguchi S, Yoshida A, Uzawa Y, Kikuchi K, Tani K, Ogawa S, Itabashi M, Yamamoto M, Watanabe D, Ando T, Morimoto S, Ichihara A. Fatal Fournier’s gangrene caused by Clostridium ramosum in a patient with central diabetes insipidus and insulin-dependent diabetes mellitus: a case report. BMC Infect Dis. 2018;18(1):363. doi: 10.1186/s12879-018-3280-9. Aug 2; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [66].Semenič D, Kolar P.. Fournier’s gangrene does not spare young adults. Wounds. 2018;30(7):E73–E76. Jul. [PubMed] [Google Scholar]
- [67].Abass-Shereef J, Kovacs M, Simon EL.. Fournier’s gangrene masking as perineal and scrotal cellulitis. Am J Emerg Med. 2018;36(9):1719. doi: 10.1016/j.ajem.2018.05.067. Sep. e1-1719.e2. [DOI] [PubMed] [Google Scholar]
- [68].Wetterauer C, Ebbing J, Halla A, Kuehl R, Erb S, Egli A, Schaefer DJ, Seifert HH. A contemporary case series of Fournier’s gangrene at a Swiss tertiary care center—can scoring systems accurately predict mortality and morbidity? World J Emerg Surg. 2018;13:25. doi: 10.1186/s13017-018-0187-0. Jun 22; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [69].Demir CY1, Yuzkat N, Ozsular Y, Kocak OF, Soyalp C, Demirkiran H. Fournier Gangrene: Association of Mortality with the Complete Blood Count Parameters. Plast Reconstr Surg. 2018;142(1):68e–75. doi: 10.1097/PRS.0000000000004516. Jul. e3. [DOI] [PubMed] [Google Scholar]
- [70].Chen Y, Wang X, Lin G, Xiao R. Successful treatment following early recognition of a case of Fournier’s scrotal gangrene after a perianal abscess debridement: a case report. J Med Case Rep. 2018;12(1):193. doi: 10.1186/s13256-018-1697-9. Jun 27; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [71].Yuan L, Xiong Q, Wang B.. Fourier’s gangrene associated with a decubitus ulcer. IDCases. 2018;12:149–150. doi: 10.1016/j.idcr.2018.05.010. May 17; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [72].Katsimantas A, Ferakis N, Skandalakis P, Filippou D. A Rare Case of Localised Isolated Penile Fournier’s Gangrene and a Short Review of the Literature. Case Rep Urol. 2018;2018:5135616. doi: 10.1155/2018/5135616. May 9; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [73].Althunayyan S, Karamitosos E. Fournier’s gangrene in an obese female in third trimester of pregnancy. Saudi Med J. 2018;39(4):415–418. doi: 10.15537/smj.2018.4.21780. Apr; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [74].Pittaka M, Georgiou C, Polyviou P, Kountourakis P, Loizou P, Constantinou I, Andreopoulos D, Vassiliou VP. Fournier Gangrene in a patient receiving chemo-radiation for rectal cancer. Oxf Med Case Reports. 2018. Feb 26;2018(2):omx101. [DOI] [PMC free article] [PubMed]
- [75].Taylor GM, Hess DV. Fournier gangrene: a rare case of necrotizing fasciitis of the entire right hemi-pelvis in a diabetic female. Oxf Med Case Reports. 2018. Feb 9; 2018(2):omx094. [DOI] [PMC free article] [PubMed]
- [76].Dos Santos DR, Roman ULT, Westphalen AP, Lovison K, Spencer Neto FAC. Profile of patients with Fournier’s gangrene and their clinical evalutation. Rev Col Bras Cir. 2018;45(1):e1430. doi: 10.1590/0100-6991e-20181430. [DOI] [PubMed] [Google Scholar]
- [77].Fukui K, Fujioka M, Ishiyama S. Sacral pressure ulcer-induced Fournier’s Gangrene extending to the retroperitoneum: a case report. Wounds. 2018;30(1):E5–E8. Jan. [PubMed] [Google Scholar]
- [78].Kuzaka B, Wróblewska MM, Borkowski T, Kawecki D, Kuzaka P, Młynarczyk G, Radziszewski P. Fournier’s Gangrene: Clinical Presentation of 13 Cases. Med Sci Monit. 2018;24:548–555. doi: 10.12659/MSM.905836. Jan 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [79].Goel A, Gupta S, Agarwal A, Shiwach N, Chawda V, Bhagat TS. Fournier’s gangrene: a rare manifestation of Chikungunya fever. Trop Doct. 2018;48(1):36–37. doi: 10.1177/0049475517699542. Jan. [DOI] [PubMed] [Google Scholar]
- [80].Ghodoussipour SB, Gould D, Lifton J, Badash I, Krug A, Miranda G, Loh-Doyle J, Carey J, Djaladat H, Doumanian L, Ginsberg D. Surviving Fournier’s gangrene: Multivariable analysis and a novel scoring system to predict length of stay. J Plast Reconstr Aesthet Surg. 2018;71(5):712–718. doi: 10.1016/j.bjps.2017.12.005. May. [DOI] [PubMed] [Google Scholar]
- [81].Tenório CEL, Lima SVC, Albuquerque AV, Cavalcanti MP, Teles F. Risk factors for mortality in fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI) Int Braz J Urol. 2018;44(1):95–101. doi: 10.1590/S1677-5538.IBJU.2017.0193. Jan-Feb; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [82].Weimer SB, Matthews MR, Caruso DM, Foster KN. Retroperitoneal Necrotizing Fasciitis from Fournier’s Gangrene in an Immunocompromised Patient. Case Rep Surg. 2017;2017:5290793. doi: 10.1155/2017/5290793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [83].Wähmann M, Wähmann M, Schütz F, Sohn C, Schott S, Kremer T, Hernekamp JF, Kneser U. Severe Fournier’s gangrene-a conjoint challenge of gynaecology and plastic surgery. J Surg Case Rep. 2017 doi: 10.1093/jscr/rjx239. Dec 8;2017(12):rjx239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [84].Wang T, Zhao G, Rui YJ, Mi JY. Bilateral fenoral posterior neurocutaneous perforater flap successfully treating Fournier gangrene: a case report. Medicine (Baltimore) 2017;96(46):e8720. doi: 10.1097/MD.0000000000008720. Nov. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [85].Yücel M, Özpek A, Başak F, Kılıç A, Ünal E, Yüksekdağ S, Acar A, Baş G. Fournier›s gangrene: A retrospective analysis of 25 patients. Ulus Travma Acil Cerrahi Derg. 2017;23(5):400–404. doi: 10.5505/tjtes.2017.01678. Sep. [DOI] [PubMed] [Google Scholar]
- [86].Üreyen O, Acar A, Gökçelli U, Atahan MK, İlhan E. Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier’s gangrene: A multicenter study. Ulus Travma Acil Cerrahi Derg. 2017;23(5):389–394. doi: 10.5505/tjtes.2017.71509. Sep. [DOI] [PubMed] [Google Scholar]
- [87].Dell’Atti L, Cantoro D, Maselli G, Galosi AB. Distant subcutaneous spreading of Fournier’s angrene: An unusual clinical identification by preoperative ultrasound study. Arch Ital Urol Androl. 2017;89(3):238–239. doi: 10.4081/aiua.2017.3.238. Oct 3; [DOI] [PubMed] [Google Scholar]
- [88].Yanaral F, Balci C, Ozgor F, Simsek A, Onuk O, Aydin M, Nuhoglu B. Comparison of conventional dressings and vacuum-assisted closure in the wound therapy of Fournier’s gangrene. Arch Ital Urol Androl. 2017;89(3):208–211. doi: 10.4081/aiua.2017.3.208. Oct 3; [DOI] [PubMed] [Google Scholar]
- [89].Chia L, Crum-Cianflone NF. Emergence of multi-drug resistant organisms (MDROs) causing Fournier’s gangrene. J Infect. 2018;76(1):38–43. doi: 10.1016/j.jinf.2017.09.015. Jan. [DOI] [PubMed] [Google Scholar]
- [90].Kordahi AM, Suliman AS. A case of Fournier’s gangrene. Eplasty. 2017. Sep 18;17:ic25. [PMC free article] [PubMed]
- [91].Hong KS, Yi HJ, Lee RA, Kim KH, Chung SS. Prognostic factors and treatment outcomes for patients with Fournier’s gangrene: a retrospective study. Int Wound J. 2017;14(6):1352–1358. doi: 10.1111/iwj.12812. Dec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [92].Sanders O, Gilbert-Kawai E, Saha R. Intravenous immunoglobulin as adjunctive treatment for Fournier’s gangrene. Br J Hosp Med (Lond) 2017;78(9):530–531. doi: 10.12968/hmed.2017.78.9.530. Sep 2; [DOI] [PubMed] [Google Scholar]
- [93].Ferretti M, Saji AA, Phillips J. Fournier’s Gangrene: A Review and Outcome Comparison from 2009 to 2016. Adv Wound Care (New Rochelle) 2017;6(9):289–295. doi: 10.1089/wound.2017.0730. Sep 1; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [94].Kumar S, Costello AJ, Colman P. Fournier’s gangrene in a man on empagliflozin for treatment of Type 2 diabetes. Diabet Med. 2017;34(11):1646–1648. doi: 10.1111/dme.13508. Nov. [DOI] [PubMed] [Google Scholar]
- [95].Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, Varnalidis I, Symeonidis S, Savvala NA, Parpoudi S, Paraskevas GK, Pramateftakis MG, Kotidis E, Mantzoros I, Tsalis KG. Fournier’s Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis. Front Surg. 2017;4:36. doi: 10.3389/fsurg.2017.00036. Jul 10; [DOI] [PMC free article] [PubMed] [Google Scholar]
- [96].Bocchiotti MA, Bogetti P, Parisi A, Rivarossa F, Frenello A, Baglioni EA. Management of Fournier’s gangrene non-healing wounds by autologous skin micrograft biotechnology: a new technique. J Wound Care. 2017;26(6):314–317. doi: 10.12968/jowc.2017.26.6.314. Jun 2. [DOI] [PubMed] [Google Scholar]
- [97].Choi H, Kim YS, Na CH, Shin BS. Fournier’s Gangrene: A Rare Complication of Sweet’s syndrome. Ann Dermatol. 2017;29(3):387–389. doi: 10.5021/ad.2017.29.3.387. Jun. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [98].Sawayama H, Miyanari N, Sugihara H, Iwagami S, Mizumoto T, Kubota T, Haga Y, Baba H. A fascia lata free flap in pelvic exenteration for Fournier gangrene due to advanced rectal cancer: a case report. Surg Case Rep. 2017;3(1):74. doi: 10.1186/s40792-017-0350-y. Dec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [99].Lauerman MH, Kolesnik O, Sethuraman K, Rabinowitz R, Joshi M, Clark E, Stein D, Scalea T, Henry S. Less is more? Antibiotic duration and outcomes in Fournier’s gangrene. J Trauma Acute Care Surg. 2017;83(3):443–448. doi: 10.1097/TA.0000000000001562. Sep. [DOI] [PubMed] [Google Scholar]
- [100].Smith MT Jr, Graham JN Jr, Levy EB, Olugbade K, Flores V, Emeruwa C, Shimonovich S, Roudnitsky V, Winer AG. Penile Preservation With Subcutaneous Transposition During Fournier’s Gangrene. Urol Case Rep. 2017;12:81–83. doi: 10.1016/j.eucr.2017.03.010. Apr 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [101].Baek SO, Park SH, Rhie JW, Han HH. Peri-vulvar reconstruction using internal pudendal artery perforator flap in female Fournier’s gangrene. Int Wound J. 2017;14(6):1378–1381. doi: 10.1111/iwj.12744. Dec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [102].Huang CS. Fournier’s Gangrene. N Engl J Med. 2017;376(12):1158. doi: 10.1056/NEJMicm1609306. Mar 23. [DOI] [PubMed] [Google Scholar]
- [103].Morais H, Neves J, Maciel Ribeiro H, Ferreira M, Guimarães N, Azenha N, Dias R, Fonseca A, Conceição L. Case series of Fournier’s gangrene: Affected body surface area - The underestimated prognostic factor. Ann Med Surg (Lond) 2017;16:19–22. doi: 10.1016/j.amsu.2017.02.043. Feb 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [104].Okumura K, Kubota T, Nishida K, Lefor AK, Mizokami K. Treatment of Complete Anal Stricture after Diverting Colostomy for Fournier’s Gangrene. Case Rep Surg. 2017;2017:2062157. doi: 10.1155/2017/2062157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [105].Osbun N, Voelzke BB. Transfer of patients with Fournier’s gangrene: in reply to Fujita. J Am Coll Surg. 2017;225(2):347–348. doi: 10.1016/j.jamcollsurg.2017.04.002. Aug. [DOI] [PubMed] [Google Scholar]
- [106].Kahn BE, Tatem AJ, Mazur DJ, Wren J, Hehemann M, Desai AS, Keeter MK, Hensley P, Walker J, Angel JB, Lewis K, Mellon MJ, Bylund JR, Bennett NE, Brannigan RE. Contemporary report of a multi-istitutional experience with fournier’s gangrene. J Urol. 2017;Vol. 197(4S) No. [Google Scholar]
- [107].Misiakos EP, Bagias G, Papadopoulos I, Danias N, Patapis P, Machairas N, Karatzas T, Arkadopoulos N, Toutouzas K, Alexakis N, Konstantoulakis MN, Zografos G, Smyrniotis V, Kouraklis G, Machairas A. Early Diagnosis and Surgical Treatment for Necrotizing Fasciitis: A Multicenter Study. Front Surg. 2017;4:5. doi: 10.3389/fsurg.2017.00005. Feb 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [108].Obi AO. Isolated Fournier’s gangrene of the penis. Niger J Clin Pract. 2016;19(3):426–430. doi: 10.4103/1119-3077.179297. May-Jun. [DOI] [PubMed] [Google Scholar]
- [109].Pernetti R, Palmieri F, Sagrini E, Negri M, Morisi C, Carbone A, Bassi P, Voce S. Fournier’s gangrene: Clinical case and review of the literature. Arch Ital Urol Androl. 2016;88(3):237–238. doi: 10.4081/aiua.2016.3.237. Oct 5. [DOI] [PubMed] [Google Scholar]
- [110].Faria SN, Helman A. Deep tissue infection of the perineum: Case report and literature review of Fournier gangrene. Can Fam Physician. 2016;62(5):405–407. May. [PMC free article] [PubMed] [Google Scholar]
- [111].Ozkan OF, Koksal N, Altinli E, Celik A, Uzun MA, Cıkman O, Akbas A, Ergun E, Kiraz HA, Karaayvaz M. Fournier’s gangrene current approaches. Int Wound J. 2016;13:713–716. doi: 10.1111/iwj.12357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [112].Yoshino H, Kawakami K, Yoshino G, Sawada K. Case of anal fistula with Fournier’s gangrene in an obese type 2 diabetes mellitus patient. J Diabetes Investig Vol. 7 No. 2 March. 2016;7:276–278. doi: 10.1111/jdi.12355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [113].Crowell W, Roberts R, Tarry S. Inflammation and Infection, Fungal Fourniers Gangrene in an Immunocompromised Patient. Urology Case Reports 4. 2016;1(-3) doi: 10.1016/j.eucr.2015.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [114].Taken K, Oncu M.R., Ergun M, Eryilmaz R, Demir C.Y., Demir M., Gunes M. Fournier’s gangrene: Causes, presentation and survival of sixty-five patients. Pak J Med Sci. 2016;32(3):746–750. doi: 10.12669/pjms.323.9798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [115].Wanis M, Nafie S. Mellon J.K. A case of Fournier’s gangrene in a young immunocompetent male patient resulting from a delayed diagnosis of appendicitis. 4. Journal of Surgical Case Reports. 2016;(1-3) doi: 10.1093/jscr/rjw058. and. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [116].Sheehy S, Kelly M.E., Francis E.C., Sweeney K.J., Hussey A. A rare case of Fournier’s Gangrene. Journal of Surgical Case Reports. 2016;5(1-3) doi: 10.1093/jscr/rjw069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [117].Sarkut P, Işık O, Öztürk E, Gülcü B, Ercan I, Yılmazlar T. Gender does not affect the prognosis of Fournier’s gangrene: a case-matched study. Ulus Travma Acil Cerrahi Derg, November. 2016;22(6):441–544. doi: 10.5505/tjtes.2016.27095. [DOI] [PubMed] [Google Scholar]
- [118].Sinha R, Arachchi A, Lee P, Marwan K. Fournier Gangrene in Pregnancy. The American College of Obstetricians and Gynecologists. 2015;125(6):541–544. doi: 10.1097/AOG.0000000000000678. [DOI] [PubMed] [Google Scholar]
- [119].Marın A, Turegano Fuentes F, Cuadrado Ayuso M, Andueza Lillo J.A., Cano Ballesteros J.C., Perez Lopez M. Predictive Factors for Mortality in Fournier’s Gangrene: A Series of 59 Cases. Cir ESP. 2015;93(1):12–17. doi: 10.1016/j.ciresp.2014.03.017. [DOI] [PubMed] [Google Scholar]
- [120].Chalya P, Igenge J.Z., Mabula J.B.. Simbila S.. Fournier’s gangrene at a tertiary health facility in northwestern Tanzania: a single centre experiences with 84 patients. BMC Res Notes. 2015;8:481. doi: 10.1186/s13104-015-1493-1. and. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [121].Namkoong H, Ishii M, Koizumi M, Betsuyaku T. Fournier’s gangrene: a surgical emergency. Springer-Verlag Berlin Heidelberg 2015. Infection. 2016;44:143–144. doi: 10.1007/s15010-015-0816-4. [DOI] [PubMed] [Google Scholar]
- [122].Schulz D, Mohor G, Solovan C. Unusual foreign body in the sigmoid colon, chronic alcohol abuse, and Fournier gangrene: a case report. Dovepress, Clinical Intervention in Aging. 2015;10:673–677. doi: 10.2147/CIA.S79609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [123].Mccormack M, Valiquette A, Ismail S. Fournier’s gangrene: A retrospective analysis of 26 cases in a Canadian hospital and literature review. Can Urol Assoc J. 2015;9(5-6):E407–10. doi: 10.5489/cuaj.2445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [124].Tarchouli M, Bounaim A, Essarghini M, Ratbi M, Belhamidi M.S., Bensal A, Zemmouri A, Ali A, Sair K. Analysis of prognostic factors affecting mortality in Fournier’s gangrene: A study of 72 cases. Can Urol Assoc J. 2015;9(11-12):E800–4. doi: 10.5489/cuaj.3192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [125].Paonam SS, Bag S. Fournier gangrene with extensive necrosis of urethra and bladder mucosa: A rare occurrence in a patient with advanced prostate cancer. Urol Ann. 2015;7(4):507–509. doi: 10.4103/0974-7796.157975. OctDec;. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [126].Oguz A, Gumus M, Turkoglu A, Bozdag Z, Ulger V.B., Agacayak E, Boyuk A. Fournier’s Gangrene: A Summary of 10 Years of Clinical Experience. Int Surg. 2015;100:934–941. doi: 10.9738/INTSURG-D-15-00036.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [127].Asahata S, Hirai Y, Ainoda Y, Fujita T, Okada Y, Kikuchi K. Fournier’s gangrene caused by Listeria Monocytogenes as the primary organism. Can J Infect Dis Med Microbiol Vol 26 No 1 January/February. 2015;26(1):44–46. doi: 10.1155/2015/501386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [128].Ye J, Xie T, Wu M, Ni P. Lu S. Negative Pressure Wound Therapy Applied Before and After Split-Thickness Skin Graft Helps Healing of Fournier Gangrene. NPWT for Treating Fournier Gangrene. 2014;Vol.94(5):1–4. doi: 10.1097/MD.0000000000000426. and. pag. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [129].Danesh H, Saboury M, Sabzi A, Saboury M, Jafary M, Saboury S. Don’t underestimate fournier’s Gangrene: report of 8 cases in 10 month survey. MJIRI. 2015;Vol. 29(172):1–5. pag. [PMC free article] [PubMed] [Google Scholar]
- [130].Ossibi P.E., Souiki T, Majdoub K, Toughrai I, Laalim S, Mazaz K, Tenkorang S, Farih M.H. Fournier gangrene: rare complication of rectal cancer. Pan African Medical Journal. 2015;20:288. doi: 10.11604/pamj.2015.20.288.5506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [131].Mahmoudi A, Hamdi A. La gangrène de Fournier compliquant un empalement. Pan African Medical Journal. 2015;21:250. doi: 10.11604/pamj.2015.21.250.7601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [132].Sarmah P.B., Khan M. Zilvetti M. Fournier’s gangrene secondary to an acutely inflamed appendix herniating into the deep inguinal ring. Journal of Surgical Case Reports. 2015. pp. 1–3. and. [DOI] [PMC free article] [PubMed]
- [133].Papadimitriou G, Koukoulaki M, Vardas K, Grigorakis A, Vougas V, Drakopoulos S. Fournier’s Gangrene due to Perioperative Iatrogenic Colon Perforation in a Renal Transplant Recipient. Saudi J Kidney Dis Transpl. 2015;26(6):1257–1261. doi: 10.4103/1319-2442.168665. [DOI] [PubMed] [Google Scholar]
- [134].Özşaker E, Yavuz M, Altınbaş Y, Köze B.S, Nurülke B. The care of a patient with Fournier’s gangrene. Ulus Travma Acil Cerrahi Derg, January. 2015;21(1):71–74. doi: 10.5505/tjtes.2015.22735. [DOI] [PubMed] [Google Scholar]
- [135].Garcıa Marın A, Turegano Fuentes F, Cuadrado Ayuso M, Andueza Lillo J.A., Cano Ballesteros J.C, Perez Lopez M. Predictive Factors for Mortality in Fournier’s Gangrene: A Series of 59 Cases. Cir ESP. 2015;93(1):12–17. doi: 10.1016/j.ciresp.2014.03.017. [DOI] [PubMed] [Google Scholar]
- [136].Toh J, Gibson K, Vanlioglu B, Ang S, Ong E. Rapid progression of perianal abscess into Fournier’s Gangrene. Royal Australasian College of surgeons. 2014. pp. 192–193. [DOI] [PubMed]
- [137].Parry N. Fournier gangrene. Clinical Case Reports. 2015;3(3):198–199. doi: 10.1002/ccr3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [138].Tena D, Losa C, Medina-Pascual M, Sáez-Nieto J.A. Fournier’s gangrene caused by Actinomyces funkei, Fusobacterium gonidiaformans and Clostridium hathewayi. Anaerobe. 2014;27:14–16. doi: 10.1016/j.anaerobe.2014.02.004. [DOI] [PubMed] [Google Scholar]
- [139].Matilsky D, Lewiss R, Whalen M, Saul T. Fournier’s Gangrene-Case Report. Med Ultrason. 2014;16(3):262–263. [PubMed] [Google Scholar]
- [140].Di Serafino M, Gullotto C, Gregorini C, Nocentini C.. A clinical case of Fournier’s gangrene: imaging Ultrasound. J Ultrasound. 2014;17:303–306. doi: 10.1007/s40477-014-0106-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [141].Galukande M, Bbaale Sekavuga D, Muganzi A, Coutinho A. Fournier’s gangrene after adult male Circumcision. International Journal of Emergency Medicine. 2014;7:37. doi: 10.1186/s12245-014-0037-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [142].Tattersall T, Thangasamy I, Reynolds J. Bilateral adrenal haemorrhage associated with heparin-induced thrombocytopaenia during treatment of Fournier gangrene. BMJ Case Rep. 2014. pp. 1–4. [DOI] [PMC free article] [PubMed]
- [143].Omisanjo OA, Bioku MJ, Ikuerowo SO, Sule GA, Esho JO. Clinical characteristics and outcome of management of Fournier’s gangrene at the Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria. Ann Afr Med. 2014;13:174–178. doi: 10.4103/1596-3519.142287. ;. [DOI] [PubMed] [Google Scholar]
- [144].Rubegni P, Lamberti A, Natalini Y. Fimiani M. Treatment of two cases of Fournier’s gangrene and review of the literature. Journal of Dermatological Treatment. 2014;25:189–192. doi: 10.3109/09546634.2012.751480. and. [DOI] [PubMed] [Google Scholar]
- [145].Dinc T, Kayilioglu SI, Sozen I, Yildiz BD. Coskun F. Fournier’s Gangrene as a Postoperative Complication of Inguinal Hernia Repair. Hindawi Publishing Corporation. Case Reports in Surgery. 2014;408217:3. doi: 10.1155/2014/408217. and. Vo. Art. ID. pag. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [146].Dayan J, Clarke-Pearson EM, Dayan E, Smith ML. Aesthetic scrotal reconstruction following extensive Fournier’s gangrene using bilateral island pedicled sensate anterolateral thigh flaps: A case report. Can Urol Assoc J. 2014;8(1-2):e114–7. doi: 10.5489/cuaj.1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [147].Ludolph I, Titel T, Beier JP, Dragu A, Schmitz M, Wullich B. Horch RE. Penile reconstruction with dermal template and vacuum therapy in severe skin and soft tissue defects caused by Fournier’s gangrene and hidradenitis suppurativa. Int Wound J. 2016;13:77–81. doi: 10.1111/iwj.12235. and. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [148].Ozkan OF, Koksal N, Altinli E, Celik A, Uzun MA, Cıkman O, Akbas A, Ergun E, Kiraz HA. Karaayvaz M. Fournier’s gangrene current approaches. Int Wound J. 2016;13:713–716. doi: 10.1111/iwj.12357. and. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [149].Shimizu T, Harada K, Akazawa S, Yamaguchi M, Inozume T, Kwamura T, Shibagaki N, Momosawa A, Shimada S. Identification of the cause of severe skin infection by Fournier transform infrared spectroscopy: A case Of Fournier’s gangrene caused by fish bone. Journal of Dermatology. 2014;41:547–550. doi: 10.1111/1346-8138.12514. [DOI] [PubMed] [Google Scholar]
- [150].Ho M, Chou A, Cheung W. Fournier’s Gangrene in an elderly woman. JAGS - Februay. 2014;62(2):402–403. doi: 10.1111/jgs.12659. –Vol. [DOI] [PubMed] [Google Scholar]
- [151].Aslanidis T, Myrou A, Peftoulidou M. Management of a young female patient with Fournier’s gangrene and Lemierre’s syndrome. The Pan African Medical Journal - ISSN 1937-8688. [DOI] [PMC free article] [PubMed]
- [152].D’Arena G, Cammarota A, Musto P. Fournier’s gangrene complicating thrombocytopenia treated with Steroids. Lancet. 2014;383:1580. doi: 10.1016/S0140-6736(13)61098-3. [DOI] [PubMed] [Google Scholar]
- [153].Perkins TA, Bieniek JM, Sumfest JM. Solitary Candida albicans Infection Causing Fournier Gangrene and Review of Fungal Etiologies. Rev Urol. 2014;16(2):95–98. [PMC free article] [PubMed] [Google Scholar]
- [154].Sliwinski A, Kavanagh LE, Bolton D, Lawrentschuk N, Crock JC. Fournier’s gangrene - delayed pedicle flap based upon the anterior abdominal wall. IBJU. 2014;40(3):423–426. doi: 10.1590/S1677-5538.IBJU.2014.03.18. [DOI] [PubMed] [Google Scholar]
- [155].Agostini T, Mori F, Perello R, Dini M, Lo Russo G. Successful combined approach to a severe Fournier’s gangrene. Indian J Plast Surg. 2014;47(1):132–136. doi: 10.4103/0970-0358.129648. JanApr. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [156].Oymacı E, Coşkun A, Yakan S, Erkan N, Uçar AD, Yıldırım M. Evaluation of factors affecting mortality in Fournier’s Gangrene: Retrospective clinical study of sixteen cases. Ulus Cerrahi Derg. 2014;30(2):85–89. doi: 10.5152/UCD.2014.2512. Jun 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [157].Eskitaşcıoğlu T, Özyazgan I, Coruh A, Günay GK, Altıparmak M, Yontar Y, Doğan F. Experience of 80 cases with Fournier’s gangrene and “trauma” as a trigger factor in the etiopathogenesis. Ulus Travma Acil Cerrahi Derg. 2014;20(4):265–274. doi: 10.5505/tjtes.2014.67670. Jul. [DOI] [PubMed] [Google Scholar]
- [158].Yılmazlar T, Işık Ö, Öztürk E, Özer A, Gülcü B, Ercan I. Fournier’s gangrene: Review of 120 patients and predictors of mortality. Ulus Travma Acil Cerrahi Derg. 2014;20(5):3337. doi: 10.5505/tjtes.2014.06870. Sep. [DOI] [PubMed] [Google Scholar]
- [159].Akbulut F, Kucuktopcu O, Sonmezay E, Simsek A, Ozgor F, Gurbuz ZG. Partial penectomy after debridement of a Fournier’s gangrene progressing with an isolated penile necrosis. Ulus Travma Acil Cerrahi Derg. 2014;20(5):385–388. doi: 10.5505/tjtes.2014.93636. Sep. [DOI] [PubMed] [Google Scholar]
- [160].Coyne C, Mailhot T, Perera P. Diagnosis of Fournier’s gangrene on bedside ultrasound. West J Emerg Med. 2014;15(2):122. doi: 10.5811/westjem.2013.10.19476. Mar. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [161].Li YD, Zhu WF, Qiao JJ, Lin JJ. Enterostomy can decrease the mortality of patients with Fournier gangrene. World J Gastroenterol. 2014;20(24):7950–7954. doi: 10.3748/wjg.v20.i24.7950. Jun 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [162].Oyaert M, Cools P, Breyne J, Heyvaert G, Vandewiele A, Vaneechoutte M, Vervaeke S, De Laere E. Sepsis with an Atopobium-Like Species in a Patient with Fournier’s Gangrene. J Clin Microbiol. 2014;52(1):364–366. doi: 10.1128/JCM.02310-13. Jan. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [163].Lee G, Hong JH. Fournier Gangrene: An Unusual Presentation Involving the Bulbous Urethra and Forming Free Gas in the Urinary Bladder. J Emerg Med. 2013;44(1):166–168. doi: 10.1016/j.jemermed.2011.05.043. Jan. [DOI] [PubMed] [Google Scholar]
- [164].Abate G, Shirin M, Kandanati V. Fournier gangrene from a thirty-two centimetre rectosigmoid foreign body. J Emerg Med. 2013;44(2):e247–249. doi: 10.1016/j.jemermed.2012.09.018. Feb. [DOI] [PubMed] [Google Scholar]
- [165].Anantha RV, Kasper KJ, Patterson KG, Zeppa JJ, Delport J, McCormick JK. Fournier’s gangrene of the penis caused by Streptococcus dysgalactiae subspecies equisimilis: case report and incidence study in a tertiary-care hospital. BMC Infect Dis. 2013;13:381. doi: 10.1186/1471-2334-13-381. Aug 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [166].Benjelloun et al; El Bachir Benjelloun EB, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, Kanjaa N, Taleb KA. Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg. 2013;8(1):13. doi: 10.1186/1749-7922-8-13. Apr 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [167].Pastore AL, Palleschi G, Ripoli A. A multistep approach to manage Fournier’s gangrene in a patient with unknown type II diabetes: surgery, hyperbaric oxygen, and vacuum-assisted closure therapy: a case report. J Med Case Rep. 2013;7:1. doi: 10.1186/1752-1947-7-1. et al. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [168].Eray IC, Alabaz O, Akcam AT, Ulku A, Parsak CK, Sakman G, Seydaoglu G. Comparison of Diverting Colostomy and Bowel Management Catheter Applications in Fournier Gangrene Cases Requiring Fecal Diversion. Indian J Surg. 2015;77(Suppl 2):438–441. doi: 10.1007/s12262-013-0868-6. Dec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [169].Bjurlin MA, O’Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier’s gangrene. Urology. 2013;81(4):752–758. doi: 10.1016/j.urology.2012.12.041. Apr. [DOI] [PubMed] [Google Scholar]
- [170].Park KR, Kim TG, Lee J, Ha JH, Kim YH. Single-stage reconstruction of extensive defects after fournier’s gangrene with an exposed iliac crest and testes. Arch Plast Surg. 2013;40(1):74–76. doi: 10.5999/aps.2013.40.1.74. Jan. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [171].Subramaniam D, Hureibi K, Zia K, Uheba M. The development of Fournier’s gangrene following rubber band ligation of haemorrhoids. BMJ Case Rep. 2013 doi: 10.1136/bcr-2013-201474. Nov 28;2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [172].Sabzi Sarvestani A, Zamiri M, Sabouri M. Prognostic factors for fournier’s gangrene; a 10-year experience in southeastern Iran. Bull Emerg Trauma. 2013;1(3):116–122. Jul. [PMC free article] [PubMed] [Google Scholar]
- [173].Katib A, Al-Adawi M, Dakkak B, Bakhsh A. A three–year review of the management of Fournier’s gangrene presented in a single Saudi Arabian institute. Cent European J Urol. 2013;66(3):331–334. doi: 10.5173/ceju.2013.03.art22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [174].Czymek R, Kujath P, Bruch HP, Pfeiffer D, Nebrig M, Seehofer D, Guckelberger O. Treatment, outcome and quality of life after Fournier’s gangrene: a multicentre study. Colorectal Dis. 2013;15(12):1529–1536. doi: 10.1111/codi.12396. Dec. [DOI] [PubMed] [Google Scholar]
- [175].Akilov O, Pompeo A, Sehrt D, Bowlin P, Molina WR, Kim FJ. Early scrotal approximation after hemiscrotectomy in patients with Fournier’s gangrene prevents scrotal reconstruction with skin graft. Can Urol Assoc J. 2013;7(7-8):E481–485. doi: 10.5489/cuaj.1405. Jul-Aug. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [176].Bakari AA, Ali N, Gadam IA, Gali BM, Tahir C, Yawe K, Dahiru AB, Mohammed BS, Wadinga D. Fistula-in-ano complicated by Fournier’s gangrene our experience in north-eastern region of Nigeria. Niger J Surg. 2013;19(2):56–60. doi: 10.4103/1117-6806.119237. Jul. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [177].Avakoudjo DGJ, Hounnasso PP, Natchagandé G, Gandaho KI, Hodonou F, Tore-Sanni R, Agounkpé MM, Paré AK. Fournier’s gangrene in Cotonou, Benin Republic. J West Afr Coll Surg. 2013;3(3):75–87. Jul Sep; [PMC free article] [PubMed] [Google Scholar]
- [178].Chan CC, Williams M. Fournier gangrene as a manifestation of undiagnosed metastatic perforated colorectal cancer. Int Surg. 2013;98(1):43–48. doi: 10.9738/CC168.1. Jan-Mar. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [179].Chan CC, Shahrour K, Collier RD, Welch M, Chang S, Williams M. Abdominal implantation of testicles in the management of intractable testicular pain in Fournier gangrene. Int Surg. 2013;98(4):367–371. doi: 10.9738/INTSURG-D-13-00113.1. Oct-Dec. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [180].Aliyu S, Ibrahim AG, Ali N, Waziri AM. Fournier’s gangrene as seen in University of Maiduguri teaching hospital. ISRN Urol. 2013;2013:673121. doi: 10.1155/2013/673121. Aug 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [181].Ozkan OF, Altýnlý E, Koksal N, Senger S, Celik A. Combining Flexi-Seal and negative pressure wound therapy for wound management in Fournier’s gangrene. Int Wound J. 2015;12(3):364–365. doi: 10.1111/iwj.12103. Jun. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [182].Vyas HG, Kumar A, Bhandari V, Kumar N, Jain A, Kumar R. Prospective evaluation of risk factors for mortality in patients of Fournier’s gangrene: A single center experience. Indian J Urol. 2013;29(3):161–165. doi: 10.4103/0970-1591.117255. Jul. [DOI] [PMC free article] [PubMed] [Google Scholar]
